Hepatic drug metabolism by CYP2D6 in critically ill adults with AKI: effect of phenotype and AKI severity

Por Lane, K, Dixon, JJ, Lee, T, Johnston, A, van Schaik, R, van Fessem, M, MacPhee, IAM, Philips, BJ
Publicado no Intensive Care Med Exp (2015)

The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer

Por Lammers, L A, Mathijssen, R H J, van Gelder, T, Bijl, M J, de Graan, A-J M, Seynaeve, C, van Fessem, M A, Berns, E M, Vulto, A G, van Schaik, R H N
Publicado em 2010